{
    "clinical_study": {
        "@rank": "83950", 
        "acronym": "ITP", 
        "arm_group": [
            {
                "arm_group_label": "ITP patients accepted splenectomy"
            }, 
            {
                "arm_group_label": "Trauma with spleen rupture underwent splenectomy"
            }
        ], 
        "biospec_descr": {
            "textblock": "The biospecimens were retained for PCR, western blotting and FACS analysis."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This project was undertaken by Qilu Hospital of Shandong University and other well-known\n      hospitals in China. In order to report the alteration on the macrophage function in the\n      spleen tissue of primary immune thrombocytopenia (ITP)."
        }, 
        "brief_title": "The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia", 
        "condition": "Immune Thrombocytopenia", 
        "condition_browse": {
            "mesh_term": "Thrombocytopenia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult ITP patients whose platelet counts remain less than 10 x 10^9/L\n\n          -  patients whose platelet counts remain less than 30 x 10^9/L and who continue to\n             experience excessive bleeding after 4 to 6 weeks of appropriate medical treatment\n\n          -  patients who have experienced a transient response to primary treatment and have\n             platelet counts less than 30 x 10^9/L after 3 months\n\n          -  require continuous glucocorticoid therapy to maintain safe platelet counts\n\n          -  Willing and able to sign written informed consent.\n\n        Exclusion Criteria:\n\n          -  Received chemotherapy or anticoagulants or other drugs affecting the platelet counts\n             within 3 months before the screening visit.\n\n          -  Current HIV infection or hepatitis B virus or hepatitis C virus infections.\n\n          -  Severe medical condition (lung, hepatic or renal disorder) other than chronic ITP.\n             Unstable or uncontrolled disease or condition related to or impacting cardiac\n             function (e.g., unstable angina, congestive heart failure, uncontrolled hypertension\n             or cardiac arrhythmia)\n\n          -  Female patients who are pregnant.\n\n          -  Have a known diagnosis of other autoimmune diseases, established in the medical\n             history and laboratory findings with positive results for the determination of\n             antinuclear antibodies, anti-cardiolipin antibodies, lupus anticoagulant or direct\n             Coombs test.\n\n          -  Patients who are deemed unsuitable for the study by the investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "15 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Chinese Adult with primary immune thrombocytopenia"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01869049", 
            "org_study_id": "ITP-Spleen", 
            "secondary_id": "81070396"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Immune Thrombocytopenia", 
            "macrophage", 
            "spleen tissue"
        ], 
        "lastchanged_date": "May 30, 2013", 
        "location": {
            "contact": {
                "email": "junpeng88@gmail.com", 
                "last_name": "Jun Peng, dr.", 
                "phone": "+8613553157577"
            }, 
            "facility": {
                "address": {
                    "city": "Jinan", 
                    "country": "China", 
                    "state": "Shandong", 
                    "zip": "250012"
                }, 
                "name": "Qilu Hospital, Shandong University"
            }, 
            "investigator": {
                "last_name": "Jun Peng, dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Study on the Alteration of Macrophage Function in the Spleen Tissue From Patients With Primary Immune Thrombocytopenia (ITP): a Multicenter, Perspective, Clinical Trial", 
        "overall_contact": {
            "email": "junpeng88@gmail.com", 
            "last_name": "Jun Peng, dr.", 
            "phone": "+8613553157577"
        }, 
        "overall_official": {
            "affiliation": "Qilu Hospital, Shandong University", 
            "last_name": "Jun Peng, dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "CR. A complete response (CR) was defined as a sustained (\u2265 3 months) platelet count \u2265 100\u00d710^9/L without recurrence of thrombocytopenia", 
                "measure": "Evaluation of platelet response (Complete Response)", 
                "safety_issue": "Yes", 
                "time_frame": "The time frame is up to 3 months per subject"
            }, 
            {
                "description": "R. A response (R) was defined as a sustained (\u2265 3 months) platelet count \u2265 30\u00d710^9/L without recurrence of thrombocytopenia", 
                "measure": "Evaluation of platelet response (R)", 
                "safety_issue": "Yes", 
                "time_frame": "The time frame is up to 3 months per subject"
            }, 
            {
                "description": "NR.No response (NR) was defined as platelet count < 30 \u00d7 10^9/L or a less than two fold increase in platelet count from baseline or the presence of bleeding. Platelet count must be measured on two occasions more than a day apart.", 
                "measure": "Evaluation of platelet response (No Response)", 
                "safety_issue": "Yes", 
                "time_frame": "The time frame is up to 3 months per subject"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01869049"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shandong University", 
            "investigator_full_name": "Ming Hou", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Measure the platelet phagocytosis ability of macrophage in vitro", 
            "measure": "Macrophage Function", 
            "safety_issue": "No", 
            "time_frame": "two weeks"
        }, 
        "source": "Shandong University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shandong University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}